NCT05098600 - The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

October 14, 2022

Study Completion Date

December 20, 2022

Conditions

Alopecia AreataAlopecia TotalisAlopecia UniversalisAlopecia Areata (& Ophiasis)Alopecia BarbaeAlopecia DiffuseAutoimmune DiseasesAutoimmune HyperthyroidismAutoimmune HypothyroidismDiabetes Mellitus, Type 1Ulcerative ColitisInflammatory Bowel DiseasesCrohn DiseaseRheumatoid ArthritisDown SyndromeAtopic DermatitisAtopic AsthmaAtopic RhinitisVitiligoPsoriasisAnkylosing SpondylitisMultiple SclerosisLupus ErythematosusCOVID-19 PandemicVaccine ReactionInfectionsAnemia, Pernicious

Interventions

OTHER

Exposure of interest

Common autoimmune and atopic conditions consist of atopic dermatitis, allergic rhinitis, asthma, Crohn's disease, ulcerative colitis, Celiac disease, Pernicious anaemia, Type 1 diabetes, Autoimmune thyroiditis (Hashimoto's thyroiditis, Grave's disease, atrophic, unspecified), rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polymyalgia rheumatica, Systemic lupus erythematosus, Sjogren syndrome, psoriasis, vitiligo, Multiple sclerosis

Trial Locations (1)

100 00

Teaching Hospital of Royal Vineguards, Prague

All Listed Sponsors

lead

Faculty Hospital Kralovske Vinohrady

OTHER_GOV